Above all, our data here showed that Andrographolide can inhibit OVA-induced asthma with a possible mechanism of ROS elimination, thus negatively regulate NF-κB and NLRP3 inflammasome activation and attenuate lung inflammation/injury in mice. This evidence concerns the gene NLRP3 and asthma.